An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device.

Autor:	Valenzuela RM; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Rai R; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Kirk BH; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Sanders JN; Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Sundar S; Department of Operations and Information Systems, David Eccles School of Business, University of Utah, Salt Lake City, Utah, USA., Hamann S; Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Glostrup, Denmark., Warner JEA; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Digre KB; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Crum AV; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Jones KP; Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Katz BJ; Department of Ophthalmology and Visual Sciences; John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
Jazyk:	angličtina
Zdroj:	Neuro-ophthalmology (Aeolus Press) [Neuroophthalmology] 2017 Apr 19; Vol. 41 (4), pp. 192-197. Date of Electronic Publication: 2017 Apr 19 (Print Publication: 2017).
DOI:	10.1080/01658107.2017.1304425
Abstrakt:	Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices ("levonorgestrel intrauterine systems", LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04% in the non-LNG-IUS population (Utah and Rigshospitalet, respectively), with no significant differences in PTC signs and symptoms among the two groups. Our investigation suggests that women with an LNG-IUS may have increased risk of developing PTC but does not suggest an LNG-IUS can cause PTC.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.